Target intelligence / Profile preview

Serpin family H member 1 (HSP47) (HSP47)

Target
HSP47
Molecular classification
Serpin, Molecular chaperone
01

Overview

Serpin family H member 1 (HSP47) is a 47 kDa heat shock protein that functions as a specialized molecular chaperone specifically for collagen synthesis within the endoplasmic reticulum (UniProt P50454). It recognizes the triple-helical structure of procollagen, specifically binding to the collagen-binding site which requires an arginine residue at the Y-position of Gly-X-Arg repeats (Widmer et al., 2012). This interaction is essential for the proper folding, stabilization, and secretion of various collagen types, including types I, II, III, IV, and V. In pathological conditions, HSP47 is significantly upregulated, driving the excessive accumulation of collagen that characterizes fibrotic diseases such as liver cirrhosis and idiopathic pulmonary fibrosis (Ito & Nagata, 2019). Therapeutic strategies targeting the HSP47 collagen-binding site include small-molecule inhibitors like Col003, which compete with procollagen for binding, and siRNA-based therapies like BMS-986263 that reduce overall protein levels (PubMed: 28334916). By inhibiting this specific chaperone, researchers aim to selectively reduce collagen deposition in fibrotic tissues without affecting other cellular protein folding processes. Clinical development has focused on localized delivery systems, such as lipid nanoparticles, to minimize systemic safety concerns related to general collagen deficiency.

Other names
SERPINH1Heat shock protein 47Collagen-binding protein 1CBP1gp46AsTP3Colligin
02

Mechanism of action

RNA interference (siRNA) to silence SERPINH1 gene expression; Small molecule inhibition of the HSP47-collagen binding interface

03

Biological functions

Collagen biosynthesisProtein foldingChaperone-mediated protein foldingEndoplasmic reticulum stress response
04

Disease associations

Liver fibrosisIdiopathic pulmonary fibrosisChronic kidney diseaseSystemic sclerosisCancer metastasis
05

Safety considerations

Potential for systemic collagen deficiencyOff-target effects in non-fibrotic tissuesRisk of bone fragility or vascular issues if not localized
06

Interacting drugs

BMS-986263 (ND-L02-s0201)

1 more in the full profile.

07

Biomarkers

Pro-collagen III N-terminal propeptide (PIIINP)HSP47 mRNA expressionEnhanced Liver Fibrosis (ELF) scoreType I collagen levels

Beyond the preview

Go deeper on Serpin family H member 1 (HSP47) (HSP47).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serpin family H member 1 (HSP47) (HSP47).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call